Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2011; Volume 201, Supplement 682
The 90th Annual Meeting of The German Physiological Society
3/26/2011-3/29/2011
Regensburg, Germany


PKB/SGK-SENSITIVE PHOSPHORYLATION OF GSK3 IN THE REGULATION OF LYMPHOCYTE FUNCTION
Abstract number: P199

*Bhavsar1 S., Merches1 K., Bobbala1 D., Alessi2 D., Lang1 F., Lang3 K.

T-lymphocyte (CTL) survival and function is critically dependent on phosphoinositide (PI) 3 kinase signaling. PI3 kinase signaling includes the PKB/Akt and SGK dependent phosphorylation of glycogen synthase kinase GSK3ab leading to GSK3 inhibition. Lithium, a known unspecific GSK3 inhibitor protects against experimental autoimmune encephalomyelitis. The present study explored, whether PKB/SGK-dependent GSK3 activity participates in the regulation of CTL survival and function. Experiments were performed in mutant mice in which PKB/SGK-dependent GSK3a,ß regulation was disrupted by replacement of the serine residue in the respective SGK/PKB-phosphorylation consensus sequence by alanine (gsk3KI). The mice were compared to corresponding wild type mice (gsk3WT). As a result, expression of surface markers in CD4 and CD8 T cells was similar in gsk3KI and gsk3WT CTL blasts but gsk3KI CTL proliferate faster and are less sensitive to activation induced cell death than gsk3WT CTL. Moreover, gsk3KI CTL are less sensitive to apoptosis than gsk3WT CTL following inhibition of PI3K (10 mM LY294002) or mTOR (100 nM mTOR inhibitor Ku-0063794). gsk3KI CTL express significantly higher perforin levels than gsk3WT. Upon stimulation with anti- CD3 2C11 (6h), gsk3KI CTL secrete significantly more TNFa and IFNg than gsk3WT CTLs. In conclusion PKB/Akt and SGK dependent phosphorylation of GSK3a,ß is a potent regulator of T lymphocyte survival and function.

To cite this abstract, please use the following information:
Acta Physiologica 2011; Volume 201, Supplement 682 :P199

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE